12:00 AM
 | 
Jan 17, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

CEP-701: Began Phase II trials

Cephalon Inc. (CEPH), West Chester, Penn.
Product: CEP-701
Business: Cancer
Therapeutic category: Cell proliferation, Signal transduction...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >